These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24624782)

  • 1. [Effect of paraneoplastic rheumatic syndrome in lung cancer patients on tumor expression of BCL-2].
    Lysenko SA
    Vopr Onkol; 2013; 59(6):731-4. PubMed ID: 24624782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of p53 expression in lung cancer of patients with paraneoplastic rheumatic syndrome.
    Lysenko SA
    Exp Oncol; 2013 Mar; 35(1):41-4. PubMed ID: 23528315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 protein expression correlates with nodal status in non small cell lung cancer.
    Groeger AM; Caputi M; Esposito V; De Luca A; Salat A; Murabito M; Giordano GG; Baldi F; Giordano A; Wolner E
    Anticancer Res; 1999; 19(1B):821-4. PubMed ID: 10216499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
    Hong X; Yang ZY; Wang M; Lu L; Li YH; Hao X; Chen GY
    Int J Mol Med; 2011 Dec; 28(6):953-60. PubMed ID: 21874222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes.
    Berrieman HK; Smith L; O'Kane SL; Campbell A; Lind MJ; Cawkwell L
    Cancer; 2005 Apr; 103(7):1415-9. PubMed ID: 15700269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
    Ohmura Y; Aoe M; Andou A; Shimizu N
    Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
    Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
    Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. bcl-2 protein in non-small-cell lung carcinoma.
    Pezzella F; Turley H; Kuzu I; Tungekar MF; Dunnill MS; Pierce CB; Harris A; Gatter KC; Mason DY
    N Engl J Med; 1993 Sep; 329(10):690-4. PubMed ID: 8393963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric examination of DNA ploidy, p53 and bcl-2 expression in primary squamous epithelial pulmonary carcinoma.
    Hołownia A; Kita J; Chyczewski L; Kozłowski M; Braszko JJ
    Rocz Akad Med Bialymst; 1999; 44():180-9. PubMed ID: 10697433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
    Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
    Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of Bcl-2 gene expression and its prognostic value in non-small cell lung cancer.
    Yilmaz A; Savaş I; Dizbay Sak S; Güngör A; Kaya A; Serinsöz E; Savaş B
    Tuberk Toraks; 2005; 53(4):323-9. PubMed ID: 16456730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
    Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
    Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
    Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
    Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung.
    LaPoint RJ; Bourne PA; Wang HL; Xu H
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):401-6. PubMed ID: 18091382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of caveolin-1 expression in primary lung cancer].
    Yu JH; Wei Q; Qi FJ; Xu HT; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):664-8. PubMed ID: 17374210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer.
    Ko E; Kim Y; Cho EY; Han J; Shim YM; Park J; Kim DH
    Ann Surg Oncol; 2013 Mar; 20(3):1005-12. PubMed ID: 23115005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer.
    Jin Y; Liu Y; Zhang J; Huang W; Jiang H; Hou Y; Xu C; Zhai C; Gao X; Wang S; Wu Y; Zhu H; Lu S
    PLoS One; 2015; 10(12):e0144187. PubMed ID: 26642205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.